Concepedia

Andrew M. Biedermann

AM

Statistics

Publications

6

Citations

231

H-Index

6

Active since

2020

Affiliations

Massachusetts Institute of Technology(Current)

University of Kansas

Howard Hughes Medical Institute

University of Washington

Bioqual

Andrew M. Biedermann is an author at Massachusetts Institute of Technology specializing in biotechnology, life sciences, and vaccinology.

ORCID

Publications per year

2020–2021

6

Publications

6

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice

Neil C. Dalvie, Sergio A. Rodriguez‐Aponte, Brittany L. Hartwell et al. · Proceedings of the National Academy of Sciences · 2021 · 101 citations · Full text

, , +16

Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered <i>Komagataella phaffii</i>

Neil C. Dalvie, Andrew M. Biedermann, Sergio A. Rodriguez‐Aponte et al. · Biotechnology and Bioengineering · 2021 · 35 citations · Full text

, , +17

Simplified Gene Knockout by CRISPR-Cas9-Induced Homologous Recombination

Neil C. Dalvie, Timothy Lorgeree, Andrew M. Biedermann et al. · ACS Synthetic Biology · 2021 · 35 citations · Full text

, , +17

Macroscopic modeling of bioreactors for recombinant protein producing <i>Pichia pastoris</i> in defined medium

Moo Sun Hong, M. Lourdes Velez‐Suberbie, Andrew J. Maloney et al. · Biotechnology and Bioengineering · 2020 · 22 citations · Full text

, , +17

Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus

Neil C. Dalvie, Joseph R. Brady, Laura E. Crowell et al. · Microbial Cell Factories · 2021 · 19 citations · Full text

, , +17

1–5 of 6